Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vacuolar-sorting protein SNF8 is a subunit of the endosomal sorting complex required for transport II (ESCRT-II) in humans, encoded by the SNF8 gene. As an integral part of the ESCRT-II complex, SNF8 is critical for the formation of multivesicular bodies (MVBs) and the sorting of ubiquitinated transmembrane proteins for lysosomal degradation. This process is essential for downregulating receptors, mediating vesicle-mediated transport, and facilitating proper autophagy. Additionally, SNF8, through ESCRT-II, may play a role in transcriptional regulation by interacting with RNA polymerase II and the transcription elongation factor ELL. Mutations in SNF8 are associated with specific neurodevelopmental disorders, notably developmental and epileptic encephalopathy and neurodevelopmental disorder with optic atrophy[1][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar-sorting protein SNF8 (SNF8).